EFPIA - NEWSLETTER

EFPIA Newsletter 11 June 2026

News

11 June 2026 Investing in health: vital for competitiveness, societal resilience and fiscal sustainability...

Countries in Central and Eastern Europe (CEE) are currently facing major demographic shifts, workforce shortages and...

10 June 2026 Extending supplementary protection certificate (SPC) could increase European R&D investment...

EFPIA publishes its position on the Biotech Act, including a comprehensive impact assessment of the European Commission’s...

Blogs

08 June 2026 Innovation in motion – Europe’s accelerating wave of new cancer medicines (Guest blog)

Over the past three decades, cancer treatment in Europe has entered a new era. One of the clearest signals of this transformation...

Europe’s Choice: The value of investing in innovation

Europe stands at a crossroads. In a world shaped by geopolitical tensions, economic fragmentation and accelerating global competition, the choices made today will determine Europe’s ability to compete, innovate and lead in the decades ahead.

Join us on 23 June in Brussels to engage in a forward-looking discussion on how Europe can turn today’s challenges into opportunities – and make the right choices for its future.

Register here.

Events

17 JUN 2026

Inaugural Forum on Life Sciences Product Liability, Policy & Dispute Resolution Europe... Brussels, Belgium

The must-attend European defense strategy forum for the life sciences litigation community. Europe’s Premier Forum for...

Learn more →

29 SEP 2026

EFGCP Better Medicines for Children Conference 2026 Amsterdam, The Netherlands

This year’s Conference offers a wide variety of sessions for attendees, and will feature distinguished speakers from...

Learn more →

What we are reading

Raising €100m for research in Europe is still very challenging, warns biotech chief 10 June 2026 (Euractiv)

Alzheimer Europe calls for equitable access to new Alzheimer's disease treatments across Europe... 08 June 2026 (Alzheimer Europe)

Interview with Iris Zemzoum – President Europe, Novartis 01 June 2026 (Pharma Boardroom)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶